MatthewMHeeneyMD(He/Him)
Pediatric Hematology & Oncology • Boston, MAAssociate Professor of Pediatrics, Harvard Medical School
Dr. Heeney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-919-3242Fax+1 617-730-0641- Is this information wrong?
Summary
- Dr. Matthew Heeney is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston Children's Hospital, and Boston Medical Center. He received his medical degree from University of Calgary Faculty of Medicine and has been in practice 22 years. He also speaks multiple languages, including French. He is experienced in hemochromatosis, iron deficiency anemia, pediatric hematology / oncology, sideroblastic anemia, and pediatric sickle cell anemia.
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1999 - 2002
McGill University Faculty Medicine HospitalPediatrics, 1995 - 1999
University of Calgary Faculty of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 2002 - 2025
VA State Medical License 2002 - 2004
NC State Medical License 1999 - 2002- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis Start of enrollment: 2005 Apr 01
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
- Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPatient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.Carolina Donado, Emily M Harris, Matthew M Heeney, Jean C Solodiuk, Christine D Greco, Natasha M Archer> ;Journal of Pain and Symptom Management. 2023 May 1
- 8 citationsConsensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.Monica L Hulbert, Deepa Manwani, Emily Riehm Meier, Ofelia A Alvarez, R Clark Brown, Michael U Callaghan, Andrew D Campbell, Thomas D Coates, Melissa J Frei-Jones, Jan...> ;Pediatric Blood & Cancer. 2023 Jan 1
- 4 citationsTicagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.Matthew M Heeney, Miguel R Abboud, Jessie Githanga, Baba P D Inusa, Julie Kanter, Alan D Michelson, Videlis Nduba, Victor Musiime, Mohini Apte, Adlette Inati, Amar M T...> ;Blood. 2022 Sep 29
- Join now to see all
Journal Articles
- The Phenotypic Spectrum of Germline YARS2 Variants: From Isolated Sideroblastic Anemia to Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic Anemia 2Matthew M Heeney, Gregory A Hale, David P Steensma, Mark D Fleming, Colin A Sieff, Lee M Hilliard, Sylvia S Bottomley, Janet L Kwiatkowski, Haematologica
Press Mentions
- VIDEO: Dosing Evaluation Trial Aims to ‘Broaden the Label’ for Sickle Cell TreatmentDecember 20th, 2021
Treating Sickle Cell Disease with HSCTFebruary 19th, 2020- Sickle Cell Disease and Quality of Life ConcernsJanuary 31st, 2020
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- French
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Boston Children's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
